The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra.

1H magnetic resonance spectroscopy studies (360 MHz) were performed on specimens of benign (n = 66) and malignant (n = 21) human prostate tissue from 50 patients, and the spectral data were subjected to multivariate analysis, specifically linear-discriminant analysis. On the basis of histopathological assessments, an overall classification accuracy of 96.6% was achieved, with a sensitivity of 100% and a specificity of 95.5% in classifying benign prostatic hyperplasia from prostatic cancer. Resonances due to citrate, glutamate, and taurine were among the six spectral subregions identified by our algorithm as having diagnostic potential. Significantly higher levels of citrate were observed in glandular than in stromal benign prostatic hyperplasia (P < 0.05). This method shows excellent promise for the possibility of in vivo assessment of prostate tissue by magnetic resonance.

[1]  R. Babaian,et al.  Algorithms for early detection of prostate cancer. Current state of the “art” , 1995 .

[2]  A. Okada,et al.  Increased aspartate and glutamate levels in both gastric and colon cancer tissues. , 1993, The Tokushima journal of experimental medicine.

[3]  L. Sillerud,et al.  Differentiation of human tumors from nonmalignant tissue by natural‐abundance 13C NMR spectroscopy , 1988, Magnetic resonance in medicine.

[4]  A. Kuesel,et al.  1H MR visible lipids in colon tissue from normal and carcinogen‐treated rats , 1995, NMR in biomedicine.

[5]  J. Kurhanewicz,et al.  Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study , 1993, Magnetic resonance in medicine.

[6]  D. Gleason.  Classification of prostatic carcinomas. , 1966, Cancer chemotherapy reports.

[7]  D Fewer,et al.  Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy , 1996, Journal of magnetic resonance imaging : JMRI.

[8]  A. Heerschap,et al.  Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy. , 1993, The Journal of urology.

[9]  J. Mohler,et al.  In vitro high resolution 1h‐spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma , 1993, Magnetic resonance in medicine.

[10]  G. Sommer,et al.  In Vitro proton spectroscopy of normal and abnormal prostate , 1991, Magnetic resonance in medicine.

[11]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[12]  Barr,et al.  Classification of Human-Tumors by High-Resolution Magnetic-Resonance Spectroscopy , 1986 .

[13]  A. Heerschap,et al.  In vitro proton magnetic resonance spectroscopy of four human prostate cancer cell lines , 1995, The Prostate.

[14]  R. Franklin,et al.  Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. , 1981, Enzyme.

[15]  References , 1971 .

[16]  Bernhard O. Palsson,et al.  Cancer cell lines , 1999 .

[17]  J Kurhanewicz,et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.

[18]  J. Saunders,et al.  Magnetic resonance spectroscopy in cancer research. , 1990, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[19]  R. Somorjai,et al.  Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. , 1996, Anticancer research.

[20]  M. Garnick,et al.  Prostate Cancer: Screening, Diagnosis, and Management , 1993, Annals of Internal Medicine.

[21]  NATIONAL CANCER INSTITUTE OF CANADA. , 1949, Canadian Medical Association journal.

[22]  J. Saunders,et al.  A simple procedure for obtaining high‐quality nmr spectra of semiquantitative value from small tissue specimens: cervical biopsies. , 1992, Magnetic resonance in medicine.

[23]  C. Arús,et al.  1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance , 1993, NMR in biomedicine.

[24]  C. Mountford,et al.  Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathology , 1993, Magnetic resonance in medicine.